SAB Biotherapeutics, Inc.SABSNASDAQ
Loading
Operating Income ContractionContracting
Percentile Rank0
Studio
Year-over-Year Change

Profit from core business operations before interest and taxes

Percentile
P0
Near historical low
vs 5Y Ago
-2.4x
Contraction
Streak
5 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$-48.95M-14.1%
2024$-42.91M-12.7%
2023$-38.08M-31.7%
2022$-28.92M-115.9%
2021$-13.39M-165.2%
2020$20.56M+337.0%
2019$-8.67M-